Fingerprint
Dive into the research topics of 'Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator
Adrian Vella, Jennifer L.R. Freeman, Imogene Dunn, Kit Keller, John B. Buse, Carmen Valcarce
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations